Innovative portfolio of solutions
Senzime for investors
We are targeting a market opportunity valued more than SEK 40 billion per year.
NEWS: ExSpiron
Non-invasive, accurate, real-time respiratory volume monitoring
ExSpiron 2Xi enables non-invasive Respiratory Volume Monitoring (RVM), which has been demonstrated to provide the most direct measurement of respiratory status and the earliest indicator of changes in respiratory status.
NEWS: TetraSens Pediatric
State-of-the-art neuromuscular blockade monitoring for children
Every child deserves a safe anesthesia procedure. TetraSens Pediatric is a sensor array that is designed for the sensitive skin of a child and engineered to deliver the most accurate results, to provide ease of mind and confidence during any surgical procedure in any surgical position.
TetraSens Pediatric has FDA 510k-clearance and is CE marked.
A Swedish medical device company
Senzime develops, manufactures and markets CE- and FDA-cleared patient monitoring systems.
Our vision is a world without anesthesia and respiratory-related complications.
CEO Statement
Accelerating sales growth in the US and Europe, strategic partnership with global leader and acquisition in the US
Pia Renaudin
CEO